07:00 , Jun 11, 2007 |  BC Week In Review  |  Company News

Cambria BioSciences LLC, Pfizer deal

Cambria will use its chemical genetics platform to identify molecular targets and modes of action of antiparasitic drug candidates from PFE's Pfizer Animal Health subsidiary. Cambria is eligible for undisclosed milestones. Cambria BioSciences LLC ,...
01:27 , May 18, 2007 |  BC Extra  |  Clinical News

Cambria unveils epilepsy program

Neurology company Cambria (Woburn, Mass.) presented a high throughput in vivo Drosophila model of epilepsy at the Neurotech Industry Investing and Partnering Conference in Millbrae, Calif. The discovery platform uses fruit flies treated with neurotoxins...
02:40 , Jan 23, 2007 |  BC Extra  |  Financial News

Bionovo raises $15.7 million

BNVI raised $15.7 million through a private placement of 10.5 million shares at $1.50, which is a 53% discount to BNVI's close of $3.20 on Friday. Investors included RA Capital; Paramount BioCapital; BioCapital Asset Management;...
08:00 , Dec 20, 2004 |  BC Week In Review  |  Company News

Cambria BioSciences LLC, The Dow Chemical Co. deal

Under a 2002 deal to develop neuroactive insecticides, Cambria received undisclosed milestone payments from DOW subsidiary Dow AgroSciences LLC (Indianapolis, Ind.). The milestones were triggered by Cambria validating targets and developing functional assays for DOW's...
07:00 , Jul 26, 2004 |  BC Week In Review  |  Company News

Cambria Biosciences LLC, Syngenta deal

The companies partnered to develop insecticides. Cambria will use its technologies to identify the mechanisms of action of small molecule compounds from SYNN for insecticides. SYNN will fund research. Cambria Biosciences LLC , Woburn, Mass....
08:00 , Nov 4, 2002 |  BC Week In Review  |  Company News

Cambria BioSciences LLC, Dow Chemical deal

Cambria and DOW subsidiary Dow AgroSciences partnered to develop neuroactive insecticides for crop protection and urban pests. Under the three-year deal, Cambria will identify the mechanism of action of a series of DOW compounds and...
08:00 , Oct 29, 2002 |  BC Extra  |  Company News

Cambria, Dow insecticide deal

Cambria BioSciences (Woburn, Mass.) and DOW subsidiary Dow AgroSciences partnered to develop neuroactive insecticides for crop protection and urban pests. Under the three-year deal, Cambria will identify the mechanism of action of a series of...